BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28574932)

  • 1. Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries.
    González-Palomares B; Coronado Martín PJ; Maestro de Las Casas ML; Veganzones de Castro S; Rafael Fernández S; Vidaurreta Lázaro M; De la Orden García V; Vidart Aragon JA
    Int J Gynecol Cancer; 2017 Jul; 27(6):1088-1095. PubMed ID: 28574932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer.
    Steffensen KD; Waldstrøm M; Brandslund I; Jakobsen A
    Gynecol Oncol; 2010 Apr; 117(1):109-16. PubMed ID: 20056267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers.
    Bhaskari J; Premalata CS; Shilpa V; Rahul B; Pallavi VR; Ramesh G; Krishnamoorthy L
    Tumour Biol; 2016 Jan; 37(1):1017-23. PubMed ID: 26264619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer.
    Komatsu H; Oishi T; Itamochi H; Shimada M; Sato S; Chikumi J; Sato S; Nonaka M; Sawada M; Wakahara M; Umekita Y; Harada T
    Int J Gynecol Cancer; 2017 Sep; 27(7):1325-1332. PubMed ID: 28557832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and significance of VEGF, miR-205 and target protein Ezrin and Lamin A/C in ovarian cancer].
    Zhou J; Liu H; Chen Y; Wen J; Li L; Wu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Feb; 39(2):142-50. PubMed ID: 24608381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population.
    Janardhan B; Vaderhobli S; Bhagat R; Chennagiri Srinivasamurthy P; Venketeshiah Reddihalli P; Gawari R; Krishnamoorthy L
    PLoS One; 2015; 10(7):e0131190. PubMed ID: 26158818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF gene polymorphisms and outcome of epithelial ovarian cancer patients.
    Camerin GR; Brito AB; Vassallo J; Derchain SF; Lima CS
    Future Oncol; 2017 Feb; 13(5):409-414. PubMed ID: 27780361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer.
    Szubert S; Szpurek D; Moszynski R; Nowicki M; Frankowski A; Sajdak S; Michalak S
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):361-9. PubMed ID: 24374756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX; Wu Y; Han HQ; Wang QH
    Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of vascular endothelial growth factor (VEGF) gene polymorphism and increased serum VEGF concentration with pancreatic adenocarcinoma.
    Sivaprasad S; Govardhan B; Harithakrishna R; Venkat Rao G; Pradeep R; Kunal B; Ramakrishna N; Anuradha S; Reddy DN
    Pancreatology; 2013; 13(3):267-72. PubMed ID: 23719599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors.
    Szubert S; Moszynski R; Michalak S; Nowicki M; Sajdak S; Szpurek D
    Microvasc Res; 2016 Sep; 107():91-6. PubMed ID: 27312585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.
    Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
    Oncotarget; 2015 Sep; 6(29):28491-501. PubMed ID: 26143638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer.
    Tapia V; Gabler F; Muñoz M; Yazigi R; Paredes A; Selman A; Vega M; Romero C
    Gynecol Oncol; 2011 Apr; 121(1):13-23. PubMed ID: 21236475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
    Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
    Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of vascular endothelial growth factor-A expression and vascular endothelial growth factor polymorphisms in epithelial ovarian cancer.
    Smerdel MP; Waldstrøm M; Brandslund I; Steffensen KD; Andersen RF; Jakobsen A
    Int J Gynecol Cancer; 2009 May; 19(4):578-84. PubMed ID: 19509553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.